BackgroundCheck.run
Search For

Michael J Hadd, 493960 Wolff St, Denver, CO 80212

Known as:
Michael Dr Hadd Michael Joseph Hadd Michael Padd
Related to:
Rachel Benincasa

Michael Hadd Phones & Addresses

Denver, CO   

Truckee, CA   

San Jose, CA   

Cedar Glen, CA   

2977 Bayside Ln, San Diego, CA 92109    858-4884816   

Tucson, AZ   

San Bernardino, CA   

Social networks

Michael J Hadd

Linkedin

Work

Company: Ambit biosciences Jul 2010 to Apr 2011 Position: Senior scientist ii medicinal chemistry

Education

School / High School: Uc San Diego 2011 to 2012 Specialities: Management, Design

Skills

Drug Discovery • Medicinal Chemistry • Drug Design • Patents • Clinical Trials • Clinical Development • Clinical • Lead Optimization • Organic Synthesis • Pharmaceutical Industry • Biochemistry • Drug Development • Dmpk • R&D • Lead Change • High Throughput Screening • Organic Chemistry

Languages

English

Industries

Pharmaceuticals
Get Report
Control this profile

Mentions for Michael J Hadd

Michael Hadd resumes & CV records

Resumes

Michael Hadd Photo 13

Michael J Hadd

Location:
4858 Winton Way, San Jose, CA 95124
Industry:
Pharmaceuticals
Work:
Ambit Biosciences Jul 2010 - Apr 2011
Senior Scientist Ii Medicinal Chemistry Biofocus Dpi and Discovery Partners Jun 2002 - Aug 2007
Scientist To Team Leader - Medicinal Chemistry
Education:
Uc San Diego 2011 - 2012
University of Arizona 1999 - 2001
Master of Business Administration, Masters, Business Administration, Management, Business University of Arizona 1993 - 1998
Doctorates, Doctor of Philosophy, Organic Chemistry Randolph - Macon College 1989 - 1993
Bachelors, Bachelor of Science, Business Economics, Business, Chemistry
Skills:
Drug Discovery, Medicinal Chemistry, Drug Design, Patents, Clinical Trials, Clinical Development, Clinical, Lead Optimization, Organic Synthesis, Pharmaceutical Industry, Biochemistry, Drug Development, Dmpk, R&D, Lead Change, High Throughput Screening, Organic Chemistry
Languages:
English

Publications & IP owners

Us Patents

Spiroheterocyclic Glycosides And Methods Of Use

US Patent:
7795228, Sep 14, 2010
Filed:
Dec 26, 2007
Appl. No.:
11/964493
Inventors:
Michael J. Hadd - San Diego CA, US
Yuanwei Chen - North Haven CT, US
Yan Feng - Shanghai, CN
Sengen Sen - San Diego CA, US
Brian Seed - Derry NH, US
Assignee:
Theracos, Inc. - Sunnyvale CA
International Classification:
A01N 43/04
C07H 1/00
C07H 3/00
C08B 37/00
US Classification:
514 23, 536 111
Abstract:
Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Glucose Transport Inhibitors And Methods Of Use

US Patent:
7803778, Sep 28, 2010
Filed:
May 22, 2007
Appl. No.:
11/752226
Inventors:
Yuanwei Chen - North Haven CT, US
Yan Feng - Shanghai, CN
Baihua Xu - Shanghai, CN
Binhua Lv - Shanghai, CN
Jiajia Dong - Shanghai, CN
Brian Seed - Derry NH, US
Michael J. Hadd - San Diego CA, US
Assignee:
Theracos, Inc. - Sunnyvale CA
International Classification:
A01N 43/04
C07H 1/00
C07H 3/00
C08B 37/00
US Classification:
514 23, 536 111
Abstract:
Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Benzylic Glycoside Derivatives And Methods Of Use

US Patent:
7838498, Nov 23, 2010
Filed:
Apr 1, 2008
Appl. No.:
12/060767
Inventors:
Yuanwei Chen - North Haven CT, US
Yan Feng - Shanghai, CN
Baihua Xu - Shanghai, CN
Binhua Lv - Shanghai, CN
Brian Seed - Derry NH, US
Michael J. Hadd - San Diego CA, US
Huawei Cheng - Shanghai, CN
Zelin Sheng - Belle Mead NJ, US
Min Xu - Shanghai, CN
Congna Wang - Shanghai, CN
Jiyan Du - Shanghai, CN
Lili Zhang - Shanghai, CN
Ge Xu - Shanghai, CN
Yuelin Wu - Shanghai, CN
Assignee:
Theracos, Inc. - Sunnyvale CA
International Classification:
A01N 43/04
A61K 31/70
C07H 1/00
US Classification:
514 23, 536 111
Abstract:
Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Benzylbenzene Derivatives And Methods Of Use

US Patent:
7838499, Nov 23, 2010
Filed:
Aug 22, 2008
Appl. No.:
12/197095
Inventors:
Yuanwei Chen - North Haven CT, US
Huawei Cheng - Shanghai, CN
Shengbin Li - Shanghai, CN
Yuelin Wu - Shanghai, CN
Yan Feng - Shanghai, CN
Binhua Lv - Shanghai, CN
Baihua Xu - Shanghai, CN
Brian Seed - Boston MA, US
Michael J. Hadd - San Diego CA, US
Yanli Song - Shanghai, CN
Jiyan Du - Shanghai, CN
Congna Wang - Shanghai, CN
Jacques Y. Roberge - Shanghai, CN
Assignee:
Theracos, Inc. - Sunnyvale CA
International Classification:
A01N 43/04
A61K 31/70
C07H 1/00
C07H 5/02
US Classification:
514 23, 536 111, 536122
Abstract:
Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Benzylbenzene Derivatives And Methods Of Use

US Patent:
8106021, Jan 31, 2012
Filed:
Nov 1, 2010
Appl. No.:
12/917367
Inventors:
Yuanwei Chen - North Haven CT, US
Huawei Cheng - Shanghai, CN
Shengbin Li - Shanghai, CN
Yuelin Wu - Shanghai, CN
Yan Feng - Shanghai, CN
Binhua Lv - Shanghai, CN
Baihua Xu - Shanghai, CN
Brian Seed - Boston MA, US
Michael J. Hadd - San Diego CA, US
Yanli Song - Shanghai, CN
Jiyan Du - Shanghai, CN
Congna Wang - Shanghai, CN
Jacques Y. Roberge - Shanghai, CN
Assignee:
Theracos, Inc. - Sunnyvale CA
International Classification:
A01N 43/04
A61K 31/70
US Classification:
514 23
Abstract:
Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Jak Kinase Modulating Compounds And Methods Of Use Thereof

US Patent:
8349851, Jan 8, 2013
Filed:
Feb 26, 2010
Appl. No.:
12/714323
Inventors:
Sunny Abraham - San Diego CA, US
Qi Chao - San Diego CA, US
Michael J. Hadd - San Diego CA, US
Mark W. Holladay - San Diego CA, US
Gang Liu - San Diego CA, US
Eduardo Setti - San Mateo CA, US
Assignee:
Ambit Biosciences Corp. - San Diego CA
International Classification:
A61K 31/517
US Classification:
51426623, 544284
Abstract:
Provided herein are quinazoline compounds of formula (I):.

Benzylbenzene Derivatives And Methods Of Use

US Patent:
8575321, Nov 5, 2013
Filed:
Dec 21, 2011
Appl. No.:
13/333295
Inventors:
Yuanwei Chen - North Haven CT, US
Huawei Cheng - Pudong New District, CN
Shengbin Li - Shanghai, CN
Yuelin Wu - Pudong New District, CN
Yan Feng - Shanghai, CN
Binhua Lv - Shanghai, CN
Baihua Xu - Shanghai, CN
Brian Seed - Boston MA, US
Michael Hadd - San Diego CA, US
Yanli Song - Pudong New District, CN
Jiyan Du - Shanghai, CN
Congna Wang - Pudong New District, CN
Jacques Roberge - Shanghai, CN
Assignee:
Theracos, Inc. - Marlborough MA
International Classification:
C07H 1/00
US Classification:
536 111
Abstract:
Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Quinazoline Compounds And Methods Of Use Thereof

US Patent:
8633207, Jan 21, 2014
Filed:
Aug 31, 2011
Appl. No.:
13/222937
Inventors:
Michael J. Hadd - San Diego CA, US
Mark W. Holladay - San Diego CA, US
Martin Rowbottom - San Diego CA, US
Assignee:
Ambit Biosciences Corporation - San Diego CA
International Classification:
A01N 43/54
A61K 31/517
C07D 239/72
C07D 401/00
US Classification:
5142661, 544283, 544284
Abstract:
Provided herein are quinazoline compounds for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.

Possible Relatives

Jim K Hadd  Linda K Hadd  Mildred V Hadd  Richard G Hadd  Michael C Last  Michael C Johnson  Michael F Stamps  Michael Stan  Michael W Stanaland  Michael Stanard 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.